IP & IT News
US claim construction at the English High Court – Chugai Pharmaceuticals Co. Ltd v UCB & Celltech
Reddie & Grose – 28 August
Reddie & Grose discuss the recent case of Chugai Pharmaceuticals Co. Ltd v UCB & Celltech  EWHC 2264 at the English High Court. The patent concerns a matter of infringement of a US patent, specifically, a licence agreement between Chugai Pharmaceutical Co. and UCB Pharma S.A. The licence specified that the English Court has exclusive jurisdiction over the scope of the licence agreement and therefore had to decide whether sales of Chugai’s product, Tocilizumab, infringed this US patent.
Data breach complaints up 160% since GDPR came into force
The Independent – 28 August
Between 25 May and 3 July 2018, the Information Commissioner’s Office (ICO) reported an increase of 160% in complaints compared to the same period the previous year. The introduction of the General Data Protection Regulation (GDPR) in May 2018 will likely have contributed to this rise.
Is there a high chance of US and UK courts grappling with medicinal cannabis patents?
Reddie & Grose – 23 August
Both the US and the UK governments have defined cannabis and its related products as having no medicinal benefits. However, both the US and UK courts have granted a number of patents ‘relating to the therapeutic use of cannabis derived products.’ Reddie & Grose discuss the effects of this paradox and the potential future laws surrounding the drug.
Has the CJEU quietly changed the conditions for safe harbour availability?
IP Kat – 22 August
The IP Kat discusses the recent Court of Justice of the European Union (CJEU) ruling ‘concerning enforcement of IP rights under Article 4(c) of the Enforcement Directive and the availability and scope of the safe harbours under the E-Commerce Directive.’